67		Specific correlations between muscle oxidative stress and chronic fatigue  syndrome: a working hypothesis.
66	Dec.	Attenuated Morning Salivary Cortisol Concentrations in a Population-based Study of Persons with Chronic Fatigue Syndrome and Well Controls.
65	Dec.	Genetic evaluation of the serotonergic system in chronic fatigue syndrome.
64	Dec.	A Matched Case Control Study of Orthostatic Intolerance in Children/Adolescents With Chronic Fatigue Syndrome.
63	Dec.	Sympathetic cardiovascular control during orthostatic stress and isometric exercise in adolescent chronic fatigue syndrome.
62	Dec.	Seven genomic subtypes of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (CFS/ME): a detailed analysis of gene networks and clinical phenotypes.
61	Dec.	Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detect active infection in patients with chronic fatigue syndrome.
60	Dec.	A real-time assessment of the effect of exercise in chronic fatigue syndrome.
59	Dec.	Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions.
58	Dec.	Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome.
57	Dec.	Identity and coping experiences in Chronic Fatigue Syndrome: a synthesis of qualitative studies.
56	Dec.	Successful use of a primary care practice-specialty collaboration in the care of an adolescent with chronic fatigue syndrome.
55	Nov.	Low grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome.
54	Nov.	Actigraphic assessment of sleep disorders in children with chronic fatigue syndrome.
53	Nov.	Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents
52	Sept. Oct.	Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
51	Sept.	Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
50	Sept.	The chronic fatigue syndrome: a comparative pathway analysis.
49	Sept.	Do diseases have a prestige hierarchy? A survey among physicians and medical students.
48	Sept.	Enterovirus infection of the stomach in Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (CFS/ME).
47	Sept.	Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach.
46	Sept.	Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: A population-based study.
45	Sept.	Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome.
44	Aug	Identity and coping experiences in Chronic Fatigue Syndrome: A synthesis of qualitative studies.
43	Aug	Publication trends in chronic fatigue syndrome: Comparisons with fibromyalgia and fatigue: 1995-2004.
42	Aug.	Symptoms of autonomic dysfunction in chronic fatigue syndrome.
41	July	Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta.
40	July	Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.
39	July	Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
38	July	Sympathetic predominance of cardiovascular regulation during mild orthostatic stress in adolescents with chronic fatigue.
37	July	Gene expression correlates of post infective fatigue syndrome after infectious mononucleosis.
36	July	Chronic fatigue syndrome after Q fever.
35	July	A twin study of cognitive function in chronic fatigue syndrome: the effects of sudden illness onset.
34	July	Abnormal thermoregulatory responses in adolescents with chronic fatigue syndrome: relation to clinical symptoms.
33	June	Multiple chemical sensitivity: study of 52 cases.
32	June	Lymphatic drainage of the neuraxis in chronic fatigue syndrome: a hypothetical model for the cranial rhythmic impulse.
31	June	Autonomic function and child chronic fatigue syndrome.
30	June	Antinuclear antibodies in patients with chronic fatigue syndrome.
29	June	Estimation of fatigue state in patient with CFS using actigraph and R-R interval power spectrum analysis.
28	June	Chronic fatigue syndrome and herpesvirus reactivation.
27	June	Chronic fatigue syndrome and neurotransmitters.
26	June	Vitamin d and rehabilitation: improving functional outcomes.
25	May	Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents.
24	May	Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia.
23	May	The impact of a 4-hour sleep delay on slow wave activity in twins discordant for chronic fatigue syndrome.
22	May	Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls.
21	Apr.	Nitric oxide synthase partial uncoupling as a key switching mechanism for the NO/ONOO- cycle.
20	Apr.	Usefulness of an abnormal cardiovascular response during low-grade head-up tilt-test for discriminating adolescents with chronic fatigue from healthy controls.
19	Apr.	Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability.
18	Apr.	The effect of cognitive behaviour therapy for chronic fatigue syndrome on self-reported cognitive impairments and neuropsychological test performance.
17	Mar.	Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.
16	Feb.	Low-resolution electromagnetic brain tomography (LORETA) of monozygotic twins discordant for chronic fatigue syndrome.
15	Feb.	Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability.
14	Feb.	Resting muscle pain as the first clinical symptom in children carrying the MTTK A8344G mutation.
13	Feb.	Defining the occurrence and influence of alpha-delta sleep in chronic fatigue syndrome.
12	Feb.	Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis:  disease mechanisms, diagnostic test and specific treatments
11	Feb.	Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome).
10	Feb.	Special problems of children with myalgic encephalomyelitis/chronic fatigue syndrome and the enteroviral link.
9	Feb.	Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works.
8	Feb.	Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome.
7	Feb.	Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome.
6	Jan.	Hypocapnia is a biological marker for orthostatic intolerance in some patients with chronic fatigue syndrome.
5	Jan.	Body mass indes and fatigue severity in CFS.
4	Jan.	Personality profile of patients with CFS.
3	Jan.	Physiological responses to arm and leg excercise in women patients with CFS.
2	Jan.	Service utilization, barriers to service access, and coping in adults with CFS.
1	Jan	Erythrocyte oxidative damage in CFS.